Investing.com - PureTech Health (NASDAQ: PRTC) reported fourth quarter EPS of $-0.24, $1.74 better than the analyst estimate of $-1.98. Revenue for the quarter came in at $3.33M versus the consensus estimate of $11M.
PureTech Health's stock price closed at $27.48. It is up 7.22% in the last 3 months and up 3.27% in the last 12 months.
PureTech Health saw positive EPS revisions and negative EPS revisions in the last 90 days. See PureTech Health's stock price’s past reactions to earnings here.
According to InvestingPro, PureTech Health's Financial Health score is "fair performance".
Check out PureTech Health's recent earnings performance, and PureTech Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar